AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19744223 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC)
Number of subjects: 131
Study 18577791 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron therapy for 12 weeks
Number of subjects: 22
Study 16172952 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus rituximab (MCP+R)
Number of subjects: 42
Study 16172952 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (MCP)
Number of subjects: 42
Study 16172952 — intervention group
Group type: COMPARATOR
Intervention: Mantle cell lymphoma treatment
Number of subjects: 42
Study 12394787 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy
Number of subjects: 0
Study 12394787 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 10432137 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg of PGE2 (Prepidil) administered intracervically at 39 weeks' gestation, repeated weekly for up to three doses.
Number of subjects: 294
Study 10432137 — intervention group
Group type: COMPARATOR
Intervention: Expectant treatment (control group).
Number of subjects: 294
Study 7548458 — intervention group
Group type: EXPERIMENTAL
Intervention: Sons of fathers diagnosed with psychoactive substance dependence (n = 28)
Number of subjects: 54
Study 7548458 — intervention group
Group type: COMPARATOR
Intervention: Matched sons of nonaffected fathers (n = 26)
Number of subjects: 54
Study 2111220 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-electrolyte solution labeled with stable isotope H2O18
Number of subjects: 0
Study 2111220 — intervention group
Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 0
Study 6134331 — intervention group
Group type: EXPERIMENTAL
Intervention: Calsyn 100
Number of subjects: 95
Study 6134331 — intervention group
Group type: EXPERIMENTAL
Intervention: Visken
Number of subjects: 95
Study 6134331 — intervention group
Group type: EXPERIMENTAL
Intervention: Grisefuline + Penthonium
Number of subjects: 95
Study 31402509 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen bisphosphonates (nBP; alendronate or risedronate)
Number of subjects: 598
Study 31402509 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidronate
Number of subjects: 598
Study 31402509 — intervention group
Group type: COMPARATOR
Intervention: Rapid bone loss
Number of subjects: 598
Study 31402509 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen bisphosphonates (nBP)
Number of subjects: 598
Study 29685019 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (BCCAs) intravenously, 5.64mL·Kg‐1·h‐1 (4KJ·Kg‐1·h‐1)
Number of subjects: 56
Study 29685019 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9%
Number of subjects: 56
Study 29685019 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (BCCAs) intravenously
Number of subjects: 56
Study 25288325 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 months' exercise program
Number of subjects: 50
Study 24495855 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-source random forest
Number of subjects: 24000
Study 24495855 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-source tariff method
Number of subjects: 24000
Study 24495855 — intervention group
Group type: EXPERIMENTAL
Intervention: InterVA-4
Number of subjects: 24000
Study 24495855 — intervention group
Group type: EXPERIMENTAL
Intervention: King-Lu method
Number of subjects: 24000
Study 24495855 — intervention group
Group type: COMPARATOR
Intervention: Physician-coded verbal autopsy (PCVA)
Number of subjects: 24000
Study 22101227 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue 200mg
Number of subjects: 22
Study 22101227 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue 400mg
Number of subjects: 22
Study 22101227 — intervention group
Group type: COMPARATOR
Intervention: Methylene blue 100mg IV
Number of subjects: 22
Study 22101227 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (200mg and 400mg)
Number of subjects: 22
Study 20678233 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered behavioural weight loss intervention focusing on physical activity, diet, and behavioural therapy (18 months duration, with a 6-month intensive phase and a 12-month maintenance phase).
Number of subjects: 300
Study 20678233 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 300
Study 17656445 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (10 microg/kg)
Number of subjects: 10
Study 17656445 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal glucose infusion (3 kcal/min for 60 min)
Number of subjects: 10
Study 17656445 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 10
Study 16783811 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (mean dose 637 mg/day, mean treatment duration 80 days)
Number of subjects: 40
Study 16783811 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine (mean dose 16 mg/day, mean treatment duration 78 days)
Number of subjects: 40
Study 15283485 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS) with appropriate postoperative care
Number of subjects: 200
Study 10783609 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual outcome-oriented cardiologic rehabilitation treatment
Number of subjects: 0
Study 10783609 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 8627110 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed antileprosy vaccine containing killed Mycobacterium leprae of human origin plus M. bovis BCG
Number of subjects: 50
Study 8627110 — intervention group
Group type: EXPERIMENTAL
Intervention: M. bovis BCG
Number of subjects: 50
Study 8627110 — intervention group
Group type: COMPARATOR
Intervention: Multidrug therapy (MDT) only
Number of subjects: 50
Study 1317909 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF)
Number of subjects: 7
Study 1317909 — intervention group
Group type: COMPARATOR
Intervention: D‐glucose (placebo)
Number of subjects: 7
Study 3918196 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% glucose‐3.3% Intralipid‐5% amino acid solution (group G‐F)
Number of subjects: 40
Study 3918196 — intervention group
Group type: COMPARATOR
Intervention: 25% glucose‐5% amino acid solution (group G)
Number of subjects: 40
Study 3918196 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens (group G and group G‐F)
Number of subjects: 40
Study 3918196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralipid addition to TPN regimen
Number of subjects: 40
Study 31706658 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula oxygen (HFNC) at a flow of 60 L/min
Number of subjects: 22
Study 31706658 — intervention group
Group type: COMPARATOR
Intervention: Conventional reserve-bag oxygen therapy (NBO2) at a flow of 15 L/min
Number of subjects: 22
Study 31706658 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula oxygen (HFNC)
Number of subjects: 22
Study 31706658 — intervention group
Group type: COMPARATOR
Intervention: Conventional reserve-bag oxygen therapy (NBO2)
Number of subjects: 22
Study 31286899 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharyngeal packing (PP)
Number of subjects: 88
Study 31286899 — intervention group
Group type: COMPARATOR
Intervention: No pharyngeal packing (non-PP)
Number of subjects: 88
Study 29231609 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 50
Study 29231609 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 50
Study 29231609 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 50
Study 25261953 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing imagery task
Number of subjects: 6
Study 25261953 — intervention group
Group type: COMPARATOR
Intervention: Braille music code task
Number of subjects: 6
Study 25261953 — intervention group
Group type: COMPARATOR
Intervention: Nonimagery activity (cloze passage)
Number of subjects: 6
Study 25261953 — intervention group
Group type: COMPARATOR
Intervention: Control (nonimagery tasks)
Number of subjects: 6
Study 23283500 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Score (MDS)
Number of subjects: 3083
Study 23283500 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-Style Dietary Pattern Score (MSDPS)
Number of subjects: 3083
Study 21992464 — intervention group
Group type: EXPERIMENTAL
Intervention: HGF/c-Met signaling activation
Number of subjects: 98
Study 21992464 — intervention group
Group type: EXPERIMENTAL
Intervention: HGF activation in liver cancer cell lines (HuH-6 and HuH-7)
Number of subjects: 98
Study 21992464 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear expression of c-Met-activated beta-catenin
Number of subjects: 98
Study 21992464 — intervention group
Group type: EXPERIMENTAL
Intervention: CTNNB1 mutation analysis
Number of subjects: 98
Study 18328929 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mug CYT006-AngQb
Number of subjects: 72
Study 18328929 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mug CYT006-AngQb
Number of subjects: 72
Study 18328929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 17283866 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine CR
Number of subjects: 505
Study 17283866 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 505
Study 14678103 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF) ablation during cardiac surgery
Number of subjects: 130
Study 14678103 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RF ablation)
Number of subjects: 130
Study 10972687 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 60 mg/m2 daily for six weeks, followed by 40 mg/m2 on alternate days for six weeks
Number of subjects: 68
Study 10972687 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone 40 mg/m2 daily for six weeks
Number of subjects: 68
Study 8774278 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal color Doppler sonography
Number of subjects: 90
Study 8774278 — intervention group
Group type: COMPARATOR
Intervention: Control group (spontaneous ovulatory cycles)
Number of subjects: 90
Study 1473873 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine hydrochloride in polyethylene glycol (MHP) suppository
Number of subjects: 17
Study 1473873 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine alkaloid in Novata BBC (MAN) suppository
Number of subjects: 17
Study 6202753 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole, 400 mg once daily (K)
Number of subjects: 48
Study 6202753 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B tablets and lozenges (A)
Number of subjects: 48
Study 6202753 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ketoconazole and amphotericin B together (K + A)
Number of subjects: 48
Study 31623622 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D Oculus Rift CV1
Number of subjects: 20
Study 31623622 — intervention group
Group type: COMPARATOR
Intervention: Laptop (LCD)
Number of subjects: 20
Study 29687877 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous adiponectin in addition to adenosine and tirofiban
Number of subjects: 66
Study 29687877 — intervention group
Group type: COMPARATOR
Intervention: Adenosine combined with micro-pump intravenous infusion of tirofiban
Number of subjects: 66
Study 27017450 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered ISTDP (n = 50)
Number of subjects: 100
Study 27017450 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (n = 50)
Number of subjects: 100
Study 25052420 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (SHGs and microfinance at baseline)
Number of subjects: 0
Study 25052420 — intervention group
Group type: COMPARATOR
Intervention: Late intervention (SHGs and microfinance after 18 months)
Number of subjects: 0
Study 25052420 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention
Number of subjects: 0
Study 25052420 — intervention group
Group type: COMPARATOR
Intervention: Late intervention
Number of subjects: 0
Study 22008899 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (topiramate plus nortriptyline)
Number of subjects: 68
Study 22008899 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (placebo)
Number of subjects: 68
Study 19353332 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin adhesive (n = 53)
Number of subjects: 100
Study 19353332 — intervention group
Group type: COMPARATOR
Intervention: Subcuticular suture (n = 47)
Number of subjects: 100
Study 17337492 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan 40/80 mg
Number of subjects: 96
Study 17337492 — intervention group
Group type: COMPARATOR
Intervention: Ramipril 5/10 mg
Number of subjects: 96
Study 15114377 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate 1.250 mg twice daily (500 mg Ca2+ per tablet)
Number of subjects: 16
Study 15114377 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 16
Study 15114377 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate 1.250 mg twice daily plus 400 IU vitamin D3 b.i.d.
Number of subjects: 16
Study 11770035 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting (OPCAB)
Number of subjects: 26
Study 11770035 — intervention group
Group type: COMPARATOR
Intervention: Conventional coronary artery bypass grafting with CPB
Number of subjects: 26
Study 9421346 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational medication management training (PMT) + cognitive psychotherapy (CP) + key‐person counselling (KC)
Number of subjects: 132
Study 9421346 — intervention group
Group type: EXPERIMENTAL
Intervention: Various combinations of PMT, CP, and KC
Number of subjects: 132
Study 9421346 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-specifically treated patients)
Number of subjects: 132
Study 8318411 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous chemotherapy in biochemically defined responders
Number of subjects: 67
Study 8318411 — intervention group
Group type: COMPARATOR
Intervention: Maintenance hormones after 6 months
Number of subjects: 67
Study 8318411 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue chemotherapy while biochemical markers kept falling or remained normal
Number of subjects: 67
Study 3011917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal recombinant alpha interferon (IFN‐alpha 2b) 1,500,000 IU twice daily
Number of subjects: 400
Study 3011917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal recombinant alpha interferon (IFN‐alpha 2b)
Number of subjects: 400
Study 3011917 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 3011917 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal recombinant alpha interferon (IFN‐alpha 2b) or placebo once daily
Number of subjects: 400
Study 30776365 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic management based on rapid diagnostic testing (RDT)
Number of subjects: 45
Study 30776365 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 45
Study 30776365 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic management based on RDT
Number of subjects: 45
Study 28728785 — intervention group
Group type: EXPERIMENTAL
Intervention: Clampless facilitating device (CFD) during off-pump CABG
Number of subjects: 142
Study 28728785 — intervention group
Group type: COMPARATOR
Intervention: Partial clamp during off-pump CABG
Number of subjects: 142
Study 28728785 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-clamp during on-pump CABG
Number of subjects: 142
Study 28728785 — intervention group
Group type: COMPARATOR
Intervention: Double-clamp during on-pump CABG
Number of subjects: 142
Study 28728785 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 CFD during off-pump CABG
Number of subjects: 142
Study 28728785 — intervention group
Group type: COMPARATOR
Intervention: >1 CFD during off-pump CABG
Number of subjects: 142
Study 26715485 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 IU of intranasal OXT
Number of subjects: 31
Study 26715485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 25726222 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehydration group (n=7)
Number of subjects: 14
Study 25726222 — intervention group
Group type: COMPARATOR
Intervention: Dehydration group (n=7)
Number of subjects: 14
Study 22027875 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic LPV/r 200/50mg BID
Number of subjects: 20
Study 22027875 — intervention group
Group type: EXPERIMENTAL
Intervention: Branded LPV/r 200/50mg BID
Number of subjects: 20
Study 22027875 — intervention group
Group type: COMPARATOR
Intervention: Both generic and branded LPV/r
Number of subjects: 20
Study 19616493 — intervention group
Group type: EXPERIMENTAL
Intervention: LAIV+OPV
Number of subjects: 2503
Study 19616493 — intervention group
Group type: COMPARATOR
Intervention: Placebo+OPV
Number of subjects: 2503
Study 19616493 — intervention group
Group type: EXPERIMENTAL
Intervention: LAIV only
Number of subjects: 2503
Study 17884346 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanical formulation (rose hips, blueberry and blackberry mixture, grapevine extract)
Number of subjects: 79
Study 17884346 — intervention group
Group type: EXPERIMENTAL
Intervention: Botanical formulation
Number of subjects: 79
Study 17884346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study 15181844 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory rate set to 12 times per minute for 30 minutes, adjusted according to calculation with 0.3 x PaCO2
Number of subjects: 42
Study 15181844 — intervention group
Group type: COMPARATOR
Intervention: Respiratory rate set to 8 times per minute
Number of subjects: 42
Study 12126522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 1.0 g/d (body weight < 50 kg) or 1.5 g/d (body weight > 50 kg), reduced to 0.75-1.0 g/d after 6 months, maintaining dosage of 0.5-0.75 g/d after 12 months, total treatment duration at least 12 months.
Number of subjects: 62
Study 12126522 — intervention group
Group type: COMPARATOR
Intervention: Control group received prednisone orally at 0.8 mg/kg/d.
Number of subjects: 62
Study 10530284 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vertical corrector (AVC) treatment followed by fixed 022 orthodontic appliances
Number of subjects: 29
Study 10530284 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 29
Study 7548920 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g lactulose
Number of subjects: 8
Study 7548920 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g inulin
Number of subjects: 8
Study 7548920 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g lactulose
Number of subjects: 8
Study 7548920 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g inulin
Number of subjects: 8
Study 7548920 — intervention group
Group type: COMPARATOR
Intervention: resistant starch (6.1 g)
Number of subjects: 8
Study 7548920 — intervention group
Group type: EXPERIMENTAL
Intervention: inulin
Number of subjects: 8
Study 7548920 — intervention group
Group type: EXPERIMENTAL
Intervention: lactulose
Number of subjects: 8
Study 7548920 — intervention group
Group type: EXPERIMENTAL
Intervention: starch
Number of subjects: 8
Study 2039059 — intervention group
Group type: COMPARATOR
Intervention: Taping
Number of subjects: 30
Study 2039059 — intervention group
Group type: COMPARATOR
Intervention: Swede‐O brace
Number of subjects: 30
Study 2039059 — intervention group
Group type: COMPARATOR
Intervention: Kallassy brace
Number of subjects: 30
Study 6783524 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition regimen consisting of 0.6 g amino acid and 4.0 g carbohydrate/kg BW/day
Number of subjects: 55
Study 6783524 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric amounts of carbohydrate (5.0 g/kg BW/day) alone
Number of subjects: 55
Study 31161236 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 baths in thermal water for a month plus standard pharmacological treatment (Group A Phase 1)
Number of subjects: 50
Study 31161236 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacological treatment (Group B Phase 1)
Number of subjects: 50
Study 31161236 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Group A Phase 2)
Number of subjects: 50
Study 31161236 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 baths in thermal water for a month plus standard treatment (Group B Phase 2)
Number of subjects: 50
Study 28085977 — intervention group
Group type: EXPERIMENTAL
Intervention: Teethmate Desensitizer (TD)
Number of subjects: 20
Study 28085977 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA; distilled water)
Number of subjects: 20
Study 26336909 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week intranasal administration of oxytocin
Number of subjects: 20
Study 22933619 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based validating interview for adolescents who self-injure
Number of subjects: 66
Study 22933619 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (not specified)
Number of subjects: 66
Study 21876564 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg A3309
Number of subjects: 36
Study 21876564 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg A3309
Number of subjects: 36
Study 21876564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 18504093 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care psychoeducational intervention
Number of subjects: 256
Study 17723083 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with amiodarone and sotalol
Number of subjects: 0
Study 17723083 — intervention group
Group type: COMPARATOR
Intervention: Sotalol monotherapy
Number of subjects: 0
Study 17723083 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone monotherapy
Number of subjects: 0
Study 14985946 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone mass consolidation during growth
Number of subjects: 266
Study 14985946 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric BMD (vBMD) at the lumbar spine and ultradistal radius (UDR) in women
Number of subjects: 266
Study 14985946 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric BMD (vBMD) at the femoral neck (FN) and UDR in men
Number of subjects: 266